Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000695709 | SCV000824224 | benign | Bloom syndrome | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001011868 | SCV001172243 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-01-30 | criteria provided, single submitter | clinical testing | The p.Q497R variant (also known as c.1490A>G), located in coding exon 6 of the BLM gene, results from an A to G substitution at nucleotide position 1490. The glutamine at codon 497 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV000695709 | SCV001522804 | uncertain significance | Bloom syndrome | 2020-01-27 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Mayo Clinic Laboratories, |
RCV004792394 | SCV005411153 | uncertain significance | not provided | 2024-05-02 | criteria provided, single submitter | clinical testing | BP4, PM2 |
Natera, |
RCV000695709 | SCV001461100 | uncertain significance | Bloom syndrome | 2018-12-17 | no assertion criteria provided | clinical testing |